期刊文献+

补体C1q肿瘤坏死因子相关蛋白1与脂联素水平的关系 被引量:2

下载PDF
导出
摘要 目的探讨健康老年人、2型糖尿病(T2DM)老年患者、T2DM合并冠心病(CHD)老年患者及CHD老年患者补体C1q肿瘤坏死因子(TNF)相关蛋白1(CTRP1)与脂联素(ADPN)水平及其关系。方法采用酶联免疫法(ELISA)测定各组患者血清CTRP1及ADPN的水平。将患者分为对照组(n=42);T2DM组(n=30);并发症组(n=32);CHD组(n=31);定义对照组、CHD组为非糖尿病(DM)组;T2DM组、并发症组为DM组。结果 DM组血清CTRP1水平明显高于非DM组。DM组CTRP1水平与ADPN水平呈负相关关系。结论 CTRP1与T2DM有关。本实验结果支持目前关于CTRP1为ADPN有效补充的观点。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2014年第14期3833-3835,共3页 Chinese Journal of Gerontology
基金 河南省卫生厅医学科技攻关计划项目(092102310008)
  • 相关文献

同被引文献34

  • 1McAlpine J N, Hanley G E, Woo M M, et al. Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention [ J/OL ]. Am J Obstet Gynecol, 2014, 210 (5) : 471. e1 - e11. doi: 10. 1016/j. ajog. 2014.01. 003.
  • 2Kuchenbaecker K B, Ramus S J, Tyrer J, et al. Identification of six new susceptibility loci for invasive epithelial ovarian cancer[ J ]. Nat Genet, 2015, 47(2) : 164-171.
  • 3Riester M, Wei W, Waldron L, et al. Risk prediction for late-stage ovarian cancer by meta-analysis of 1525 patient samples[ J]. J Natl Cancer Inst, 2014, 106 (5). pii: dju048, doi: 10. 1093/jnci/ dju048.
  • 4Burger R A, Brady M F, Bookman M A, et al. Risk factors for GI adverse events in a phase Ⅲ randomized trial of bevacizumab in first-line therapy of advanced ovarian cancer: A Gynecologic Oncology Group Study[ J]. J Clin Oncol, 2014, 32(12) : 1210 -1217.
  • 5Devapatla B K, Sharma A, Woo S. Interleukin-8 mediates resistance to anti-VEGF therapy in ovarian cancer [ J]. Cancer Res, 2014, 74( 19 Suppl) : 2999.
  • 6Carbone F, Math F, Montecucco F. The role of adipocytokines in atherogenesis and atheroprogression [ J ]. Curr Drug Targets, 2015, 16(4) : 295 -320.
  • 7Lei H, Wu D, Wang JY, et al. Clq/tumor necrosis factor-related protein-6 attenuates post-infarct cardiac fibrosis by targeting RhoA/ MRTF-A pathway and inhibiting myofibroblast differentiation[ J/OL]. Basic Res Cardiol, 2015, 110(4) : 35. doi: 10. 1007/s00395 - 015 -0492 -7.
  • 8Schaffler A, Buechler C. CTRP family: linking immunity to metabolism [J]. Trends Endocrinol Metab, 2012, 23(4) : 194 -204.
  • 9Lee W, Kim M J, Park E J, et al. ClqTNF-related protein-6 mediates fatty acid oxidation v/a the activation of the AMP-activated protein kinase[J]. FEBS lett, 2010, 584(5): 968-972.
  • 10Wu W J, Mo D L, Zhao C Z, et al. Knockdown of CTRP6 inhibits adipogenesis via lipogenic marker genes and Erk1/2 signalling pathway[J]. Cell Bio Int, 2015, 39(5): 554-562.

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部